Safety and efficacy of second-line axitinib versus sorafenib in metastatic renal cell carcinoma by duration of prior therapy: Subanalyses from a phase III trial Meeting Abstract
| Authors: | Escudier, B.; Motzer, R. J.; Lim, H. Y.; Porfiri, E.; Zalewski, P.; Kannourakis, G.; Tarazi, J.; Rosbrook, B.; Kim, S.; Rini, B. I. |
| Abstract Title: | Safety and efficacy of second-line axitinib versus sorafenib in metastatic renal cell carcinoma by duration of prior therapy: Subanalyses from a phase III trial |
| Meeting Title: | 17th European Cancer Conference (ECCO 17) |
| Journal Title: | European Journal of Cancer |
| Volume: | 49 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2013 Sep 27-Oct 1 |
| Meeting Location: | Amsterdam, Netherlands |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2013-09-01 |
| Start Page: | S673 |
| End Page: | S674 |
| Language: | English |
| ACCESSION: | WOS:000326843604198 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(13)70064-9 |
| Notes: | Meeting Abstract: 2795 -- 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity -- SEP 27-OCT 01, 2013 -- Amsterdam, NETHERLANDS -- Source: Wos |
